Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
Posted:
Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
#Healthcare leaders, are you balancing #Interoperability & #DataPrivacy?
Direct EHR access offers benefits but also risks like breaches & revenue loss. Learn safeguards for secure data sharing.
Read more here.
Social care aims to improve the lives of people who need help in their daily living.
Join NIHR webinar to explore how research could improve care for: People experiencing homelessness, People with learning disabilities, People living with dementia.
Secure your…
Attendees
Sponsors and Exhibitors
Webinars
Contact us